Data vs. dogma: HIV-1 integrations driving clonal selection

Molecular Therapy

Volumn 22, Issue 9, 2014, Pages 1557-1558

  Baum, Christopher ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

BACH2 PROTO ONCOGENE; CELL EXPANSION; CELL POPULATION; CLONAL EVOLUTION; CYTOPATHOGENIC EFFECT; DATA BASE; DNA MODIFICATION; EDITORIAL; GENE EXPRESSION REGULATION; GENE THERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MLK2 PROTO ONCOGENE; MONONUCLEAR CELL; MURINE LEUKEMIA VIRUS; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PROTO ONCOGENE; RISK ASSESSMENT; SAFETY; T LYMPHOCYTE; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION; GENE VECTOR; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY;

GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; VIRUS INTEGRATION;

EID: 84906852959     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.144     Document Type: Editorial

References (7)

1. Schroder, AR, Shinn, P, Chen, H, Berry, C, Ecker, JR and Bushman, F (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529. (Pubitemid 35232295)
2. Maldarelli, F, Wu, X, Su, L, Simonetti, FR, Shao, W, Hill, S et al. (2014). HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345: 179-183.
3. Akagi, K, Suzuki, T, Stephens, RM, Jenkins, NA and Copeland, NG (2004). RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32: D523-D527. (Pubitemid 38081713)
4. Cavazzana-Calvo, M, Payen, E, Negre, O, Wang, G, Hehir, K, Fusil, F et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 467: 318-322.
5. Montini, E, Cesana, D, Schmidt, M, Sanvito, F, Bartholomae, CC, Ranzani, M et al. (2009). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 119: 964-975.
6. Heckl, D, Schwarzer, A, Haemmerle, R, Steinemann, D, Rudolph, C, Skawran, B et al. (2012). Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia. Mol Ther 20: 1187-1195.
7. Stein, S, Ott, MG, Schultze-Strasser, S, Jauch, A, Burwinkel, B, Kinner, A et al. (2010). Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16: 198-204.